LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Agios Pharmaceuticals

Therapeutics aimed at cellular targets in cancer metabolism, e.g., IDH1, IDH2, and PKM2.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Agios Pharmaceuticals plus 6117 other startups.

Learn More About Agios Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More